Showing results (71-80 of 175) with videos related to

Sort By:
Pageof 18
Clinical Lymphoma, Myeloma & Leukemia|July 17, 2014
Clinical features of patients with Philadelphia-negative myeloproliferative neoplasms complicated by portal hypertensionMatthew Yan, Holly Geyer, Ruben Mesa, et al.
Hemasphere|February 20, 2020
Modifiable Lifestyle and Medical Risk Factors Associated With Myeloproliferative NeoplasmsAndrew S Duncombe, Lesley A Anderson, Glen James, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 21, 2018
Patient-Reported Outcomes Data From REVEAL at the Time of Enrollment (Baseline): A Prospective Observational Study of Patients With Polycythemia Vera in the United StatesRuben Mesa, Ralph V Boccia, Michael R Grunwald, et al.
Annals of Hematology|May 9, 2020
Real-world risk assessment and treatment initiation among patients with myelofibrosis at community oncology practices in the United StatesSrdan Verstovsek, Jingbo Yu, Jonathan K Kish, et al.
Nature Reviews. Disease Primers|April 17, 2025
Polycythaemia veraClaire N Harrison, Tiziano Barbui, Prithviraj Bose, et al.
Ejhaem|November 29, 2023
The <i>JAK2</i> mutation and the role of therapeutic agents in alleviating myeloproliferative neoplasm symptom burdenLai Yee Orbell, Nouf Abutheraa, Andrew S Duncombe, et al.
BJGP Open|July 30, 2024
Pathways to myeloproliferative neoplasm presentation and time to diagnosis: results from a cross-sectional studyEmma-Louise Tarburn, Lisa Iversen, Charlotte Robertson, et al.
Advances in Therapy|June 12, 2026
Assessment of the MFSAF v4.0 and PROMIS Fatigue 7a to Measure Outcomes in Myelofibrosis: Validation from a Non-interventional Mixed Methods StudyAmy Howerter, Helen Doll, Angela Stroupe, et al.
American Journal of Hematology|December 10, 2014
Association of the blood eosinophil count with hematological malignancies and mortalityChristen L Andersen, Volkert D Siersma, Hans C Hasselbalch, et al.
American Journal of Hematology|June 27, 2015
Myeloproliferative neoplasm patient symptom burden and quality of life: evidence of significant impairment compared to controlsLesley A Anderson, Glen James, Andrew S Duncombe, et al.
Pageof 18